Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001140361-25-005113

President sold 4,000 shares at an average $12.22 ($48,860)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ma Songjiang President 2025-02-14 Sale 10b5-1 −2,000 $11.94 $23,880 2,869,260 I: show line 1 in the form
Ma Songjiang President 2025-02-18 Sale 10b5-1 −2,000 $12.49 $24,980 2,867,260 I: show line 2 in the form
Open-market sales · 4,000 sh · avg $12.22 · $48,860
Loading xslF345X05/form4.xml…